Enhancing Radiation Safety for Nuclear Medicine Radiographers: the Impact of Introducing the Automat-ed Radiopharmaceutical Preparation and Administration System
Launched by IRCCS SAN RAFFAELE · Apr 15, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a new automated system for preparing and giving radiopharmaceuticals—substances used in nuclear medicine—can improve the safety of radiographers who work with these materials. Radiographers are healthcare professionals who help patients during imaging tests that use radiation. The goal is to find out if using this automated system can reduce the radiation exposure these workers face, making their jobs safer.
To participate in this study, you need to be a nuclear medicine radiographer with experience in manually preparing and administering these substances. You also need to be able to give written consent to take part. The trial is not yet recruiting participants, so it’s still in the planning stages. If you qualify and decide to join, you can expect to help gather important information that could lead to safer practices in nuclear medicine. This research will benefit not only the radiographers but also improve patient care by ensuring safer working conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1)Nuclear medicine radiographers with experience in manual prepa-ration of radiopharmaceuticals.
- • 2) Nuclear medicine healthcare professionals with experience in radiopharmaceutical administration.
- • 3) Ability to provide written informed consent.
- Exclusion Criteria:
- • 1) Nuclear medicine radiographers without experience in manual preparation of radiopharmaceuticals.
- • 2) Nuclear medicine healthcare professionals without experience in radiopharmaceutical administration.
- • 3) Inability to provide written informed consent.
About Irccs San Raffaele
IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milano, , Italy
Patients applied
Trial Officials
Arturo Chiti
Study Director
IRCCS Ospedale San Raffaele
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported